Where to Buy Semax: A Spray Bottle Has No Milligrams

The right-hand column is the whole point of this page. A channel that cannot be converted into dollars per milligram has not quoted you a price, it has quoted you a package.

Two of the four rows fail on the same thing rather than on price: they do not tell you what you bought. That is not a purity argument, it is an arithmetic one. You cannot say a bottle is cheap or expensive until you know how many milligrams are in it.

Research suppliers are the only sellers openly listing Semax in the US, and the reason is regulatory rather than commercial: with no approved product and no compounding route, research material is what is left. The listing costed above is a 10 mg vial of lyophilised powder, red cap, silver crimp, with two published certificates.

The tiers are worth reading once and then ignoring for a single purchase. A 10% bulk discount cannot catch a 50% code, and whether the two combine in the cart is not documented anywhere on the listing, so treat the checkout total as the only authority. The five-vial tier does clear the $250 free-shipping threshold at list, which the single discounted vial does not.

The same channel comparison for the neighbouring compound, with the same tier arithmetic, is on our Selank channel guide.

This is the channel most people actually meet first, because Semax reached consumers as a nasal spray long before research vials were easy to buy. The problem is not that sprays are worse. It is that a spray is priced in a unit that hides the mass.

The conversion is simple once you insist on it. A solution labelled 1% is 1 g per 100 mL, which is 10 mg/mL. So a 3 mL bottle at 1% holds 30 mg, and at 0.1% it holds 3 mg: a tenfold difference behind two labels that look nearly identical on a shelf. If a listing states only millilitres, or only a number of sprays, it has not told you what is in the bottle, and no price comparison is possible.

Two further things change with the format. A pre-mixed solution has already started its shelf clock, where lyophilised powder has not, so a spray is buying stability you cannot see. And sterility expectations differ: a multi-use bottle usually contains a preservative, which is another ingredient the label may not quantify. Our Selank spray versus vial comparison works the same conversion for the other Russian heptapeptide.

Ascension sells the vial, not a spray, so anyone searching where to buy Semax nasal spray is looking at a different product class rather than a different vendor.

This is the row people expect to be the safe one, and it is the row with nothing in it. Semax appears in no category of FDA's 503A bulk drug substances lists, which were last updated on 14 May 2026. It was nominated, it was placed in category 2 under the interim policies while the agency evaluated it, and the nomination was then withdrawn by the nominator. FDA's safety-risks page records that table as substances previously in category 2 that were withdrawn by the nominators, and Semax sits in it alongside sixteen others.

Pages saying Semax is FDA Category 2 or banned are quoting a status that no longer applies, and the correction is not permissive. A compounder needs a substance to be on a bulks list, the subject of an applicable monograph, or a component of an approved drug. Semax is none of those, so there is nothing for a prescription to be written against.

FDA's stated reason, worth reading once in its own words:

Compounded drugs containing semax (heptapeptide) may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities. FDA has no, or limited, safety-related information for proposed routes of administration. Therefore, the agency lacks sufficient information to know whether the drug would cause harm if administered to humans.

Overseas sellers usually quote the lowest sticker, and a sticker is not a landed cost. Three lines get added after checkout and none of them is printed: international freight, transit time on a compound that ships cold, and the possibility that the parcel does not arrive at all. A seized package converts a $20 vial into an infinite cost per milligram, because the denominator is zero milligrams.

The testing question is worse. Certificates on these listings are frequently generic rather than batch-specific, undated, or attached to a lot number that does not appear on the vial. FDA's concern is immunogenicity from aggregation and peptide-related impurities, and an endotoxin figure is the part of that a buyer can actually check. A certificate that cannot be matched to your box answers nothing, whatever numbers it prints.

Set against that, a domestic listing at $3.00 a milligram with a dispatch cut-off and free carriage over $250 is not the cheap option or the expensive one. It is the one where the arithmetic is finished at checkout. The same trade is worked through for a compound priced per 100 mg on our NAD+ channel comparison, and for a market with no measured-quantity line at all on our BPC-157 channel guide.

The channel decision ends at the doorstep, and the remaining arithmetic is handling maths rather than advice about administering anything.

A 10 mg vial reconstituted with 2 mL of solvent is 5 mg/mL. A U-100 barrel puts 0.01 mL in one unit, so a unit holds 50 mcg, ten units hold 500 mcg, and the vial is 200 units: twenty 500 mcg draws at $1.50 each, or 15 cents a unit. Choosing 1 mL instead doubles the concentration to 10 mg/mL and halves the resolution, without changing what a milligram cost.

One line from the certificates complicates it usefully. The June batch reports 11.23 mg of net content against a 10 mg label, so 2 mL actually gives 5.615 mg/mL and ten units hold 561.5 mcg. That 12.3% is invisible on a syringe and it is why the assayed rate is $2.67 a milligram rather than $3.00. Our reconstitution guide and syringe measurement guide cover both halves of that.